Partnered Content
Learn about the critical role the right CRO plays in successfully navigating the significant drug development opportunities in Japan.
Access key stats from biotechs on the latest trends impacting oncology R&D, including therapeutic pipelines and clinical trial challenges, AI/ML, and a future outlook on innovation.
Gain exclusive insights into the biggest challenges biotechs face in oncology and uncover the latest opportunities to accelerate drug development.
CGTs are among the fastest-growing areas in therapeutics - explore the key strategies driving long-term commercial success across the entire product lifecycle.
Explore the challenges and opportunities of CAR T-cell therapy, a promising new treatment for addressing the unmet needs of autoimmune diseases.
Discover how transforming field reps from “Wild Cards” to “Masters of the Message” in Pharma Omnichannel Marketing, enhances performance and mitigates risk.
Discover Henlius’ groundbreaking achievements, and their mission to deliver affordable, innovative drugs worldwide through strategic partnerships.
Access key takeaways from a roundtable on the evolving landscape for rAAV-based gene therapies. Experts discussed approaches to clinical development, regulatory barriers, and the future outlook for AAV developers and lab services organizations.
Discover how eClinical technology is transforming clinical trials, increasing efficiencies, streamlining processes, and speeding time to market. Explore what lies ahead for eClinical tech and what it means for stakeholders in terms of innovation, collaboration, and overcoming tough challenges in clinical research.
Overcoming Immunogenicity And Safety Assessment Challenges For Biologics And Biosimilars In Oncology
Expert panelists discuss regulatory challenges, flexible approaches to assay selection, and applying scientific reasoning with guidelines to address immunogenicity and safety assessment challenges in oncology biologics and biosimilars.
In Sept 2024, a new CMDO, DMX Pharma, emerged on the global market. Explore the benefits of this merger, from production capacity to cross-selling capability, regulatory expertise and their ambitious future plans.
Learn more about how China’s biopharmas are going global by working with dependable and trustworthy companion diagnostics partners.
In this podcast, Janelle Hart, Managing Editor at Citeline, teams up with industry experts Mai Yee Mishir, Senior Director of Global Regulatory Affairs, and Sally-Ann McDowell, Senior Director of Clinical Development Strategy at Advanced Clinical, to discuss the vital role of HRQoL in clinical trials.